Skip to main content

Table 1 Demographic and Treatment Characteristics of patients

From: Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: a real-world experience

Characteristics

Number

Percentage

Gender

 Male

56

69.1

 Female

25

30.9

Age at diagnosis

 < 30 y

49

60.5

 ≥ 30 y

32

39.5

Primary site

 Extremity

25

30.9

 Trunk

56

69.1

Tumor origin

 Skeletal

57

70.4

 Extraskeletal

24

29.6

Stage

 Localized

48

59.3

 Metastatic

33

40.7

Diameter of primary tumor

 < 8 cm

50

61.7

 ≥ 8 cm

31

38.3

Local therapy

 Surgery

35

43.2

 Radiotherapy

18

22.2

 Surgery + radiotherapy

28

34.6

Number of chemotherapy cycles

 < 12

40

49.4

 ≥ 12

41

50.6

Frequency of chemotherapy delays

 <  25%

65

80.2

 ≥25%

16

19.8

Administration of dexrazoxane

 YES

39

48.1

 NO

42

51.9